Virtue® SAB in the Treatment of Coronary ISR Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Virtue® SAB in the Treatment of Coronary ISR Trial — Stella

Recruiting

Back to Coronary Artery Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

St. Francis Hospital, Roslyn, New York

The Lindner Center for Research at Christ Hospital, Cincinnati, Ohio

Key details

Sponsor

Orchestra BioMed, Inc

Enrollment target

~740 participants

Started

October 2025

Primary completion

October 2028

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov